Project Details
Description
PROJECT NARRATIVE
Multidrug resistant tuberculosis is a growing threat that urgently requires new therapeutic strategies. Here, we
develop complementary biomimetic technologies that, when paired, selectively kill tuberculosis pathogens to
rapidly clear drug-resistant pulmonary disease and inhibit transmission.
Multidrug resistant tuberculosis is a growing threat that urgently requires new therapeutic strategies. Here, we
develop complementary biomimetic technologies that, when paired, selectively kill tuberculosis pathogens to
rapidly clear drug-resistant pulmonary disease and inhibit transmission.
| Status | Active |
|---|---|
| Effective start/end date | 11/19/21 → 10/31/22 |
Funding
- National Institute of Allergy and Infectious Diseases: $396,522.00
Fingerprint
Explore the research topics touched on by this project. These labels are generated based on the underlying awards/grants. Together they form a unique fingerprint.